Artificial Intelligence | Machine Learning | Machine Perception Exscientia | Accelerate Drug Discovery & Development


Enterprise, Biotechnology, Pharmaceuticals & Medical Product, Drug Design, Small Molecules Oxford, Oxfordshire, United Kingdom

Exscientia

Artificial Intelligence | Machine Learning | Machine Perception


Exscientia | Accelerate Drug Discovery & Development

Exscientia

Biotechnology, Pharmaceuticals & Medical Product, Drug Design, Small Molecules


Oxford, Oxfordshire, United Kingdom

We are the leading pharma tech company and the first to automate drug discovery. Our aim is to make safer, more sophisticated drugs available to all - more quickly and efficiently than ever before

At the forefront of small molecule drug discovery, We are the first company to automate drug design, surpassing conventional human endeavor. Our AI-driven systems actively learn best practices from vast repositories of discovery data and are further enhanced with knowledge acquired from seasoned drug hunters. With better information to hand than any researcher could acquire individually, our knowledge-driven systems design millions of novel, project-specific compounds and pre-assess each for predicted potency, selectivity, ADME, and other key criteria. From this, a selection of the best, information-rich compounds is selected for synthesis and assay.

 

B2B

26 to 50

Series C

$103,671,986

N/A

2012

 
 

Pharmaceuticals and Medical Products
Pharmaceuticals
Biotechnology

N/A

Increase Productivity

 
 

Production
IT and Security

Yes

Active

 
 

   Machine Learning
   Machine Perception
   Natural Language Processing


Kubernetes

Kubernetes

Docker

Docker

LIMS

LIMS


N/A

 

   Software


Cloud Formation

Cloud Formation

Terraform

Terraform

API

API

Azure

Azure

GCP

GCP

AWS

AWS

Phoenix

Phoenix

Flask

Flask

Django

Django

Python

Python

Angular

Angular

React

React

Vue

Vue

CSS3

CSS3

HTML5

HTML5

Typescript

Typescript

Javascript

Javascript

GraphQL

GraphQL

DynamoDB

DynamoDB

Swagger

Swagger


Neural Networks

Neural Networks

 
 

Feb 2021

  • Exscientia and the University of Oxford Announce Partnership to Develop Treatments for Alzheimer?s Disease

Nov 2018

  • Exscientia Acquired Kinetic Discovery Ltd. for an Undisclosed Amount

Oct 2017

  • Exscientia Wins Best Emerging Biotech Company Award at OBN Annual Awards 2017
 
 

View All

View All AI/ML Jobs

Data Engineer

Dundee, Scotland

Computational Drug Designer

Miami, Florida

Director Computational Drug Design

Miami, Florida

Executive Director Drug Design

Miami, Florida

Join our Miami talent pool

Miami, Florida

 

AI/ML Professionals

Want to work at Exscientia?

We can introduce you to the right person at Exscientia

Talk to our Talent Team

 

10

1

$225M

Company was founded 2012 and it took almost 9 years (Apr 2021) to raise first external round

 
 

Date

Round

$ Raised

Investors

04/27/2021

Series D

$225M

CMC Capital Group, CMC Capital Group, Pivotal bioVenture Partners, Pivotal bioVenture Partners, Novo Holdings, Marshall Wace, Marshall Wace, Mubadala Capital Ventures, Mubadala Capital Ventures, Laurion Capital Management, Laurion Capital Management, GT Healthcare Capital, GT Healthcare Capital, Farallon Capital Management, Farallon Capital Management, Casdin Capital, Casdin Capital, BlackRock Private Equity Partners,, BlackRock Private Equity Partners,

Date : 04/27/2021

Round: Series D

$ Raised: $225M

Investors: CMC Capital Group, CMC Capital Group, Pivotal bioVenture Partners, Pivotal bioVenture Partners, Novo Holdings, Marshall Wace, Marshall Wace, Mubadala Capital Ventures, Mubadala Capital Ventures, Laurion Capital Management, Laurion Capital Management, GT Healthcare Capital, GT Healthcare Capital, Farallon Capital Management, Farallon Capital Management, Casdin Capital, Casdin Capital, BlackRock Private Equity Partners,, BlackRock Private Equity Partners,

 

Investors

Interested in researching Exscientia?

We have plenty of data and we can help. Our deal sourcing platform can help you perform more research about Exscientia

Request a Demo - Deal Souring Platform

 
Willem van Hoorn


Willem van Hoorn
Chief Decision Scientist

Dave Hallett


Dave Hallett
Chief Operating Officer

Adrian Schreyer


Adrian Schreyer
Chief Research Engineer

Jeremy Besnard


Jeremy Besnard
Chief Designer

Richard Bickerton


Richard Bickerton
Chief Informatics Officer

 
 

Potential Customers

Interested in what they do or partnership?

Learn more about how they work

Schedule a Call w/ Exscientia